20 mg, 60 count bottles Duloxetine Delayed-Release Capsules USP, 30 mg, 30 count bottles According to the FDA enforcement reports, the drugs were recalled due to the "presence of N-nitroso ...

The recall includes several different formulations of duloxetine delayed-release capsules. The impacted lots cover 20 mg, 30 mg, and 60 mg dosages, across various bottle sizes ranging from 30 to ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II ...

The recall affected over 233,003 30-count, 90-count and 1,000-count bottles of 60 mg Duloxetine capsules. The FDA does not suggest that patients stop taking Duloxetine immediately but instead talk ...

19. According to the FDA, 233,003 bottles have been recalled (delayed-release capsules 30 count, 90 count and 1000 count bottles included). The bottles were distributed nationwide. Duloxetine is ...

In October, more than 7,000 bottles of 500-count 20 mg duloxetine delayed-release capsules produced by Towa Pharmaceutical Europe were also recalled over the potential presence of N-nitroso ...

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey ... have been recalled (delayed-release capsules 30 count, 90 count and 1000 count bottles included.) ...

An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...

bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.